A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Clinical trial NCT06806033 · RECRUITING
Trial details
- NCT number
- NCT06806033
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-05
- Primary completion
- 2027-01-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.